• Ontario Researcher Awarded Grant to Develop Precision Medicine Tool for CF
  • Kalydeco Seen as Safe in Treating Young Children, Ages 1 to 2, in Phase 3 Trial, Vertex Reports
  • UF Study Links Proton Pump Inhibitor Use with More Frequent Hospitalization in CF Patients
  • Virtual Reality Used In Hospital For Cystic Fibrosis ‘Distraction Therapy’
  • Scientists Explore New Way to Generate Stem Cell-like Cells for CF Therapy
  • Don’t Let Our Differences Divide the Cystic Fibrosis Community
  • Underwood Foundation, International Biophysics Partner to Provide AffloVests to 50 CF Patients
  • CF Foundation Supports Phase 3 Trial of AeroVanc, Inhaled Antibiotic for MRSA Infections, with $5M Award
  • Phase 1b Trial of ELX-02 to Possibly Treat Nonsense Mutations in CF and Other Diseases Begins
  • Liquid Formulas Made for Girl with Cerebral Palsy Spin into Company Favored by CF Patients, Too
  • AIT’s Nitric Oxide Therapy Helps CF Patients with an Infection Breathe and Function Better
  • Genetic Screening Helps Identify Risk of Having Child with CF, Australian Study Shows